ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 170 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,247 | +194.5% | 496,012 | +271.1% | 0.02% | +240.0% |
| Q4 2023 | $763 | -44.9% | 133,654 | -37.7% | 0.01% | -54.5% |
| Q2 2023 | $1,386 | -27.1% | 214,557 | -14.9% | 0.01% | -31.2% |
| Q1 2023 | $1,902 | +4.1% | 252,192 | +39.8% | 0.02% | -40.7% |
| Q4 2022 | $1,827 | -99.9% | 180,350 | +3.2% | 0.03% | +17.4% |
| Q3 2022 | $1,728,000 | -38.2% | 174,750 | -33.4% | 0.02% | -32.4% |
| Q2 2022 | $2,796,000 | +122.6% | 262,503 | +103.7% | 0.03% | +112.5% |
| Q1 2022 | $1,256,000 | +6.1% | 128,851 | +55.6% | 0.02% | +33.3% |
| Q4 2021 | $1,184,000 | +79.7% | 82,825 | +176.3% | 0.01% | +71.4% |
| Q2 2021 | $659,000 | +109.9% | 29,972 | +224.3% | 0.01% | +40.0% |
| Q1 2021 | $314,000 | -73.0% | 9,243 | -68.0% | 0.01% | -54.5% |
| Q4 2020 | $1,161,000 | – | 28,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |